Terms: = Prostate cancer AND SFRP4, Q6FHJ7, 6424, ENSG00000106483, frpHE, MGC26498, FRPHE, FRP-4
16 results:
1. Investigation of iso-propylchaetominine anticancer activity on apoptosis, cell cycle and Wnt signaling pathway in different cancer models.
Karamad V; Sogutlu F; Ozkaya FC; Shademan B; Ebrahim W; El-Neketi M; Avci CB
Fitoterapia; 2024 Mar; 173():105789. PubMed ID: 38158162
[TBL] [Abstract] [Full Text] [Related]
2. Identification of senescence-related molecular subtypes and key genes for prostate cancer.
Feng DC; Zhu WZ; Shi X; Xiong Q; You J; Wei Q; Yang L
Asian J Androl; 2023; 25(2):223-229. PubMed ID: 36124532
[TBL] [Abstract] [Full Text] [Related]
3. Study on the
Natarajan A; Sudha Bandla S; Damodaran M; Sundaram S; Venkatesan V
J Genet; 2020; 99():. PubMed ID: 33361638
[TBL] [Abstract] [Full Text] [Related]
4. Secreted Frizzled-Related Protein 4 (sfrp4) Is an Independent Prognostic Marker in prostate cancers Lacking TMPRSS2: ERG Fusions.
Bernreuther C; Daghigh F; Möller K; Hube-Magg C; Lennartz M; Lutz F; Rico SD; Fraune C; Dum D; Luebke AM; Eichenauer T; Möller-Koop C; Schlomm T; Wittmer C; Huland H; Heinzer H; Graefen M; Haese A; Burandt E; Tsourlakis MC; Clauditz TS; Höflmayer D; Izbicki JR; Simon R; Sauter G; Minner S; Steurer S; Meiners J
Pathol Oncol Res; 2020 Oct; 26(4):2709-2722. PubMed ID: 32677026
[TBL] [Abstract] [Full Text] [Related]
5. Epigenetic demethylation of sFRPs, with emphasis on sfrp4 activation, leading to Wnt signalling suppression and histone modifications in breast, prostate, and ovary cancer stem cells.
Deshmukh A; Arfuso F; Newsholme P; Dharmarajan A
Int J Biochem Cell Biol; 2019 Apr; 109():23-32. PubMed ID: 30710752
[TBL] [Abstract] [Full Text] [Related]
6. sfrp4 gene expression is increased in aggressive prostate cancer.
Sandsmark E; Andersen MK; Bofin AM; Bertilsson H; Drabløs F; Bathen TF; Rye MB; Tessem MB
Sci Rep; 2017 Oct; 7(1):14276. PubMed ID: 29079735
[TBL] [Abstract] [Full Text] [Related]
7. Secreted Frizzled-related protein 4 (sfrp4) chemo-sensitizes cancer stem cells derived from human breast, prostate, and ovary tumor cell lines.
Deshmukh A; Kumar S; Arfuso F; Newsholme P; Dharmarajan A
Sci Rep; 2017 May; 7(1):2256. PubMed ID: 28536422
[TBL] [Abstract] [Full Text] [Related]
8. SFRP1 repression in prostate cancer is triggered by two different epigenetic mechanisms.
García-Tobilla P; Solórzano SR; Salido-Guadarrama I; González-Covarrubias V; Morales-Montor G; Díaz-Otañez CE; Rodríguez-Dorantes M
Gene; 2016 Nov; 593(2):292-301. PubMed ID: 27570179
[TBL] [Abstract] [Full Text] [Related]
9. Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy.
Mortensen MM; Høyer S; Lynnerup AS; Ørntoft TF; Sørensen KD; Borre M; Dyrskjøt L
Sci Rep; 2015 Nov; 5():16018. PubMed ID: 26522007
[TBL] [Abstract] [Full Text] [Related]
10. The current use of active surveillance in an Australian cohort of men: a pattern of care analysis from the Victorian prostate cancer Registry.
Weerakoon M; Papa N; Lawrentschuk N; Evans S; Millar J; Frydenberg M; Bolton D; Murphy DG
BJU Int; 2015 Apr; 115 Suppl 5():50-6. PubMed ID: 25601201
[TBL] [Abstract] [Full Text] [Related]
11. Secreted frizzled-related protein 4 and its implications in cancer and apoptosis.
Pohl S; Scott R; Arfuso F; Perumal V; Dharmarajan A
Tumour Biol; 2015 Jan; 36(1):143-52. PubMed ID: 25501511
[TBL] [Abstract] [Full Text] [Related]
12. Gene expression and epigenetic discovery screen reveal methylation of SFRP2 in prostate cancer.
Perry AS; O'Hurley G; Raheem OA; Brennan K; Wong S; O'Grady A; Kennedy AM; Marignol L; Murphy TM; Sullivan L; Barrett C; Loftus B; Thornhill J; Hewitt SM; Lawler M; Kay E; Lynch T; Hollywood D
Int J Cancer; 2013 Apr; 132(8):1771-80. PubMed ID: 22915211
[TBL] [Abstract] [Full Text] [Related]
13. Low AZGP1 expression predicts for recurrence in margin-positive, localized prostate cancer.
Yip PY; Kench JG; Rasiah KK; Benito RP; Lee CS; Stricker PD; Henshall SM; Sutherland RL; Horvath LG
Prostate; 2011 Nov; 71(15):1638-45. PubMed ID: 21432866
[TBL] [Abstract] [Full Text] [Related]
14. Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer.
Horvath LG; Lelliott JE; Kench JG; Lee CS; Williams ED; Saunders DN; Grygiel JJ; Sutherland RL; Henshall SM
Prostate; 2007 Jul; 67(10):1081-90. PubMed ID: 17476687
[TBL] [Abstract] [Full Text] [Related]
15. Membranous expression of secreted frizzled-related protein 4 predicts for good prognosis in localized prostate cancer and inhibits PC3 cellular proliferation in vitro.
Horvath LG; Henshall SM; Kench JG; Saunders DN; Lee CS; Golovsky D; Brenner PC; O'Neill GF; Kooner R; Stricker PD; Grygiel JJ; Sutherland RL
Clin Cancer Res; 2004 Jan; 10(2):615-25. PubMed ID: 14760084
[TBL] [Abstract] [Full Text] [Related]
16. WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer.
Wissmann C; Wild PJ; Kaiser S; Roepcke S; Stoehr R; Woenckhaus M; Kristiansen G; Hsieh JC; Hofstaedter F; Hartmann A; Knuechel R; Rosenthal A; Pilarsky C
J Pathol; 2003 Oct; 201(2):204-12. PubMed ID: 14517837
[TBL] [Abstract] [Full Text] [Related]